SEC Form 4 · accession 0001019687-16-005499
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Masatsune Okajima
Officer — VP and Head of Japanese Office
Period of report
Mar 14, 2016
Accepted (ET)
Mar 16, 2016 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 14, 2016 | X | 8,400 | $3.56 | A | 51,138 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (Right to Buy) | $3.56 | Mar 14, 2016 | X | 8,400 | D | Mar 29, 2011 | Mar 29, 2016 | Common Stock | 8,400 | 0 | D |
Explanation of responses
- F1Includes shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).